Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients

The efficacy and safety of icodextrin has been well established. In this paper, we will discuss the pharmacokinetics and biocompatibility of icodextrin and its clinical effect on fluid management in peritoneal dialysis patients. Novel strategies for its prescription for peritoneal dialysis patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Dousdampanis, Periklis, Trigka, Konstantina, Bargman, Joanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556437/
https://www.ncbi.nlm.nih.gov/pubmed/23365749
http://dx.doi.org/10.1155/2013/424915
_version_ 1782257185142603776
author Dousdampanis, Periklis
Trigka, Konstantina
Bargman, Joanne M.
author_facet Dousdampanis, Periklis
Trigka, Konstantina
Bargman, Joanne M.
author_sort Dousdampanis, Periklis
collection PubMed
description The efficacy and safety of icodextrin has been well established. In this paper, we will discuss the pharmacokinetics and biocompatibility of icodextrin and its clinical effect on fluid management in peritoneal dialysis patients. Novel strategies for its prescription for peritoneal dialysis patients with inadequate ultrafiltration are reviewed.
format Online
Article
Text
id pubmed-3556437
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-35564372013-01-30 Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients Dousdampanis, Periklis Trigka, Konstantina Bargman, Joanne M. Int J Nephrol Review Article The efficacy and safety of icodextrin has been well established. In this paper, we will discuss the pharmacokinetics and biocompatibility of icodextrin and its clinical effect on fluid management in peritoneal dialysis patients. Novel strategies for its prescription for peritoneal dialysis patients with inadequate ultrafiltration are reviewed. Hindawi Publishing Corporation 2013 2013-01-08 /pmc/articles/PMC3556437/ /pubmed/23365749 http://dx.doi.org/10.1155/2013/424915 Text en Copyright © 2013 Periklis Dousdampanis et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Dousdampanis, Periklis
Trigka, Konstantina
Bargman, Joanne M.
Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title_full Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title_fullStr Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title_full_unstemmed Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title_short Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
title_sort bimodal solutions or twice-daily icodextrin to enhance ultrafiltration in peritoneal dialysis patients
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556437/
https://www.ncbi.nlm.nih.gov/pubmed/23365749
http://dx.doi.org/10.1155/2013/424915
work_keys_str_mv AT dousdampanisperiklis bimodalsolutionsortwicedailyicodextrintoenhanceultrafiltrationinperitonealdialysispatients
AT trigkakonstantina bimodalsolutionsortwicedailyicodextrintoenhanceultrafiltrationinperitonealdialysispatients
AT bargmanjoannem bimodalsolutionsortwicedailyicodextrintoenhanceultrafiltrationinperitonealdialysispatients

Ejemplares similares